SynthesisInfectious diseases of poverty2026
A reservoir at the gates: nonhuman mammalian hosts for human schistosomiasis in western Africa and the critical challenge for elimination.
Synthesis in Infectious diseases of poverty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSchistosomiasis, a snail-borne parasitic disease of public health and veterinary importance in tropical areas, is highly prevalent in sub-Saharan Africa, particularly in West Africa. The World Health Organization (WHO) has established ambitious goals of eliminating schistosomiasis as public health problem or interrupting its transmission by 2030. The zoonotic transmission of schistosomiasis involving nonhuman mammals (NHMs) complicates disease endemicity and hinders the attainment of these objectives. This study synthesized recent trends and the prevalence of human-infective schistosomes (HISs), including Schistosoma mansoni, S. haematobium, S. haematobium × S. bovis hybrids, S. guineensis, and S. intercalatum-across 16 West African countries.
methodsWe conducted a systematic literature search from March 25 to April 30, 2025, across PubMed, Scopus, Embase, and Web of Science, to identify studies on HISs (S. mansoni, S. haematobium, S. haematobium × S. bovis, S. guineensis, and S. intercalatum) in NHMs in western Africa. In addition, we manually searched African Journal Online (AJOL) and screened the references of the included articles. The data were organized in Microsoft Excel 2021 and analyzed via GraphPad Prism to identify publication trends, NHM infection incidence, and species-specific positivity rates (with 95% CIs). The spatial distribution of HIS-infected NHMs was visualized with QGIS to pinpoint high-risk areas.
resultsFour countries (Benin, Ghana, Nigeria, and Senegal) reported cases of HIS infection in NHMs with an overall prevalence of 8% (95% CI: 7-9%). Benin had the highest proportion of infected hosts (50%, 95% CI: 40-60%) and Senegal had the lowest proportion (5%, 95% CI: 4-6%). Bos taurus (60% prevalence) was the most affected species and served as a reservoir for S. haematobium × S. bovis hybrids, whereas S. mansoni exhibited an extensive distribution among rodent and primate hosts.
conclusionFor effective elimination, integrated control strategies-spanning NHM surveillance, snail intermediate host monitoring, and human mass drug administration-must be prioritized. Policy reforms should address zoonotic transmission risks, particularly in high-prevalence zones, to align interventions with the complex ecology of schistosomiasis in West Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.